Jade Biosciences, Inc. (BOATS:JBIO) IPO
IPO
Went public as Aerovate Therapeutics, Inc. Priced at US$14.00 a share on Jun 29, 2021.
- Price
- US$14.00 a share
- Shares offered
- 8,682,142 shares of common stock
- Offering size
- US$121.5 million
- Underwriters' option
- Up to 1,302,321 more shares
- Listing
- AVTE on the Nasdaq Global Market
- Underwriters
- Jefferies, Cowen, Evercore ISI, Wedbush PacGrow · In the order on the cover
- Shares delivered
- On or about Jul 2, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 6, 2021 |
| Filed publicly | Jun 9, 2021 |
| Amended 3 times | Newest Jun 25, 2021 |
| Shares registered with an exchange | Jun 25, 2021 |
| Declared effective by the SEC | Jun 29, 2021 |
| Final prospectus, with the price | Jun 30, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 30, 2021 |
| EFFECT · Notice that a registration is effective | Jun 29, 2021 |
| S-1MEF · Registration of more shares for the same offering | Jun 29, 2021 |
| CERT · Exchange's certificate of listing | Jun 29, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 25, 2021 |
| CORRESP · Letter to the SEC | Jun 25, 2021 |
| CORRESP · Letter to the SEC | Jun 25, 2021 |
| S-1/A · Registration statement, amended | Jun 25, 2021 |
| CORRESP · Letter to the SEC | Jun 24, 2021 |
| S-1/A · Registration statement, amended | Jun 24, 2021 |
| UPLOAD · Letter from the SEC | Jun 21, 2021 |
| S-1/A · Registration statement, amended | Jun 17, 2021 |
| CORRESP · Letter to the SEC | Jun 9, 2021 |
| S-1 · Registration statement | Jun 9, 2021 |
| UPLOAD · Letter from the SEC | Jun 2, 2021 |
| DRS · Draft registration statement | May 6, 2021 |
From the cover of the final prospectus (424B4) filed Jun 30, 2021